Karyopharm Initiates Third Registration-Directed Clinical Trial of Oral Selinexor
December 11, 2014 at 08:02 AM EST
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced the initiation of the SADAL study, ...